These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 36722483)
1. A Review on the Synthesis and Anticancer Potentials of Imidazothiazole Derivatives. Kamboj P; Mahore A; Husain A; Shaquiquzzaman M; Alam MM; Amir M Mini Rev Med Chem; 2023; 23(17):1733-1759. PubMed ID: 36722483 [TBL] [Abstract][Full Text] [Related]
2. Thiazole and Related Heterocyclic Systems as Anticancer Agents: A Review on Synthetic Strategies, Mechanisms of Action and SAR Studies. Sahil ; Kaur K; Jaitak V Curr Med Chem; 2022 Aug; 29(29):4958-5009. PubMed ID: 35306982 [TBL] [Abstract][Full Text] [Related]
3. The design and development of imidazothiazole-chalcone derivatives as potential anticancer drugs. Kamal A; Kashi Reddy M; Viswanath A Expert Opin Drug Discov; 2013 Mar; 8(3):289-304. PubMed ID: 23317445 [TBL] [Abstract][Full Text] [Related]
4. Modification of imidazothiazole derivatives gives promising activity in B-Raf kinase enzyme inhibition; synthesis, in vitro studies and molecular docking. Ammar UM; Abdel-Maksoud MS; Mersal KI; Ali EMH; Yoo KH; Choi HS; Lee JK; Cha SY; Oh CH Bioorg Med Chem Lett; 2020 Oct; 30(20):127478. PubMed ID: 32781217 [TBL] [Abstract][Full Text] [Related]
5. A Medicinal Chemist's Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents. Nehra B; Mathew B; Chawla PA Curr Top Med Chem; 2022; 22(6):493-528. PubMed ID: 35021975 [TBL] [Abstract][Full Text] [Related]
6. Bestowal of Quinazoline Scaffold in Anticancer Drug Discovery. Das R; Mehta DK; Dhanawat M Anticancer Agents Med Chem; 2021; 21(11):1350-1368. PubMed ID: 32593282 [TBL] [Abstract][Full Text] [Related]
7. Benzimidazole Scaffold as Anticancer Agent: Synthetic Approaches and Structure-Activity Relationship. Shrivastava N; Naim MJ; Alam MJ; Nawaz F; Ahmed S; Alam O Arch Pharm (Weinheim); 2017 Jun; 350(6):. PubMed ID: 28544162 [TBL] [Abstract][Full Text] [Related]
8. 1,3,4-Oxadiazole Containing Compounds As Therapeutic Targets For Cancer Therapy. Ahsan MJ Mini Rev Med Chem; 2022; 22(1):164-197. PubMed ID: 33634756 [TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme. El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of imidazo[2,1-b]thiazole-based anticancer agents in one decade (2011-2020): Current status and future prospects. Sbenati RM; Semreen MH; Semreen AM; Shehata MK; Alsaghir FM; El-Gamal MI Bioorg Med Chem; 2021 Jan; 29():115897. PubMed ID: 33316752 [TBL] [Abstract][Full Text] [Related]
11. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities. Yang M; Liu H; Zhang Y; Wang X; Xu Z Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464 [TBL] [Abstract][Full Text] [Related]
12. Chalcone Scaffolds as Anticancer Drugs: A Review on Molecular Insight in Action of Mechanisms and Anticancer Properties. Shukla S; Sood AK; Goyal K; Singh A; Sharma V; Guliya N; Gulati S; Kumar S Anticancer Agents Med Chem; 2021; 21(13):1650-1670. PubMed ID: 33238850 [TBL] [Abstract][Full Text] [Related]
13. Review of anticancer potentials and structure-activity relationships (SAR) of rhodanine derivatives. Yin LJ; Bin Ahmad Kamar AKD; Fung GT; Liang CT; Avupati VR Biomed Pharmacother; 2022 Jan; 145():112406. PubMed ID: 34785416 [TBL] [Abstract][Full Text] [Related]
14. Recent contributions of pyridazine as a privileged scaffold of anticancer agents in medicinal chemistry: An updated review. Liu ZQ; Zhang Q; Liu YL; Yu XQ; Chui RH; Zhang LL; Zhao B; Ma LY Bioorg Med Chem; 2024 Sep; 111():117847. PubMed ID: 39121679 [TBL] [Abstract][Full Text] [Related]
15. Azole-Pyrimidine Hybrid Anticancer Agents: A Review of Molecular Structure, Structure Activity Relationship, and Molecular Docking. Eze CC; Ezeokonkwo AM; Ugwu ID; Eze UF; Onyeyilim EL; Attah IS; Okonkwo IV Anticancer Agents Med Chem; 2022 Aug; 22(16):2822-2851. PubMed ID: 35306990 [TBL] [Abstract][Full Text] [Related]
16. DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents. Raimondi MV; Randazzo O; La Franca M; Barone G; Vignoni E; Rossi D; Collina S Molecules; 2019 Mar; 24(6):. PubMed ID: 30909399 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in synthetic strategies and SAR of thiazolidin-4-one containing molecules in cancer therapeutics. Sharma A; Sharma D; Saini N; Sharma SV; Thakur VK; Goyal RK; Sharma PC Cancer Metastasis Rev; 2023 Sep; 42(3):847-889. PubMed ID: 37204562 [TBL] [Abstract][Full Text] [Related]
18. 1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design. Faheem ; Karan Kumar B; Venkata Gowri Chandra Sekhar K; Chander S; Kunjiappan S; Murugesan S Expert Opin Drug Discov; 2021 Oct; 16(10):1119-1147. PubMed ID: 33908322 [No Abstract] [Full Text] [Related]
19. Screening of indole derivatives as the potent anticancer agents on dihydrofolate reductase: pharmaco-informatics and molecular dynamics simulation. Abdolmaleki B; Maddah M J Biomol Struct Dyn; 2023 May; 41(8):3667-3679. PubMed ID: 35318890 [TBL] [Abstract][Full Text] [Related]
20. 2-Anilinoquinoline based arylamides as broad spectrum anticancer agents with B-RAF El-Damasy AK; Haque MM; Park JW; Shin SC; Lee JS; EunKyeong Kim E; Keum G Eur J Med Chem; 2020 Dec; 208():112756. PubMed ID: 32942186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]